Cookies

We use cookies on this site to enable the site to function properly and to enhance your user experience. Cookies are files stored in your browser, which most website use to personalize your web experience. By continuing to browse the site you are giving your consent for us to set cookies. If you wish to restrict or block cookies which are set on your device then you can do this through your browser settings.

Find out more about cookies here: Privacy Policy

Ok

External site

External Link

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Continue

I am a healthcare professional

Notice

Welcome to Medically. This website is a non-promotional international resource intended to facilitate transparent scientific exchange regarding developments in medical research and disease management. It is intended for healthcare professionals outside the United States of America (US), the United Kingdom (UK) and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Roche does not support, endorse or recommend the unapproved use of any compound or service in your jurisdiction, including those discussed on this website. Please refer to local product information for any medicinal products mentioned. Information available on this website does not constitute professional medical advice and Roche accepts no responsibility for access to or use of the same. To access the full range of product and disease information, congress and educational materials available on this website, you will be required to register and log-in. By clicking “I confirm” below you are confirming that you are a healthcare professional outside the US, the UK, and Australia that you have read and understood this message and that you are requesting access to Medically.

I confirm Cancel

This website is intended only for healthcare professionals outside the US, UK and Australia.

  • View Account
    View Account
    Sign Out
  • Log in
  • Sign Up
  • Specialities
  • Conferences
  • Services
  • Rheumatology

    Oncology

    Neuroscience

    Respiratory

    Ophthalmology

    Gastro immunology

    Haematology

  • Rheumatology

    Giant Cell Arteritis Rheumatoid Arthritis

    Oncology

    Breast Cancer Genitourinary (GU) Cancer Lung Cancer

    Neuroscience

    Alzheimer's Disease

    Respiratory

    Idiopathic Pulmonary Fibrosis

    Ophthalmology

    Geographic Atrophy

    Gastro immunology

    Crohn's disease & Ulcerative colitis

    Haematology

    Haemophilia Leukemia & Lymphoma
  • Rheumatology

    Oncology

    Neuroscience

    Respiratory

    Ophthalmology

    Gastro immunology

    Haematology

  • Rheumatology

    ACR 2018 EULAR 2018 ACR 2017 EULAR 2017

    Oncology

    ASCO GU 2019 ASCO GI 2019 ESMO 2018 WCGC 2018 EBCC 2018 SABCS 2018 Melanoma Skin Cancer 2018 ESMO Asia 2018 WCLC 2018 ASCO 2018 EHA 2018 ESMO 2017 ASCO GU 2018 SABCS 2017 ASCO GI 2018 AACR 2018 ELCC 2018

    Neuroscience

    AAT-ADPD 2019 HSG 2018 WMS 2018 ICNMD 2018 EHDN 2018 ECTRIMS 2018 EAN 2018 CTAD 2018 CSMA 2018 CNS 2018 AAT-ADPD 2018 AAN 2018 AAIC 2018

    Respiratory

    AIR 2018 ERS 2018 ATS 2018 ERS 2017

    Ophthalmology

    AAO 2018 EURETINA 2018

    Gastro immunology

    UEG Week 2018

    Haematology

    ASH 2018
  • Clinical Trials ForPatients Investigator Initiated Studies Medical Information Request Pipeline Research Cancer Immunotherapy Website
Home Oncology ASCO GI 2019

Roche at ASCO GI 2019

The Gastrointestinal (GI) Cancers Symposium is a multidisciplinary and specialised oncology event designed for healthcare professionals and the research community. This three-day meeting covers emerging science as well as innovative therapy options for malignancies of the oesophagus, stomach, pancreas, small bowel, colon, rectum, and anus.

San Francisco, USA

17-19 January 2019

Posters
  • PDF
    Jan 18, 2019  | Gastrointestinal Cancer
    PDF
    ASCO GI 2019

    ASCO-GI_Poster_2019_MORPHEUS: a Phase Ib/II study platform evaluating the safety and clinical activity of cancer immunotherapy (CIT)-based combinations in gastrointestinal (GI) cancers

    Jan 18, 2019  | Gastrointestinal Cancer
    Gastrointestinal Cancer
    MORPHEUS is a flexible, comprehensive study platform of multiple randomised Phase Ib/II trials designed to efficiently evaluate the clinical activity and safety of various treatment combinations in patients with different tumour types. This Trial in Progress poster presents the CIT combinations, eligibility criteria, endpoints, and enrolment sites for patients with the following tumour types: pancreatic ductal adenocarcinoma, gastric and gastro-oesophageal junction cancer, and colorectal cancer.
© 2017 F. Hoffmann-La Roche Ltd
  • About Us
  • Legal Statement
  • Privacy Policy
  • Contact Us
  • Sitemap
Follow us here

This website is intended for healthcare professionals outside the United States of America (US), the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.